Search Results - "AZROLAN, N"

Refine Results
  1. 1

    ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes by Plump, A S, Azrolan, N, Odaka, H, Wu, L, Jiang, X, Tall, A, Eisenberg, S, Breslow, J L

    Published in Journal of lipid research (01-05-1997)
    “…The major high density lipoprotein (HDL) apolipoprotein, apoA-I, was knocked out by gene targeting in ES cells to provide a model for the study of HDL…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Intestinal expression of the human apoA-I gene in transgenic mice is controlled by a DNA region 3' to the gene in the promoter of the adjacent convergently transcribed apoC-III gene by Walsh, A, Azrolan, N, Wang, K, Marcigliano, A, O'Connell, A, Breslow, J L

    Published in Journal of lipid research (01-04-1993)
    “…The apoA-I gene in humans is principally expressed in liver and small intestine. Using transgenic mice, we previously showed that 256 bp of 5' flanking DNA was…”
    Get full text
    Journal Article
  4. 4

    Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism : studies in transgenic mice by HAYEK, T, AZROLAN, N, VERDERY, R. B, WALSH, A, CHAJEK-SHAUL, T, AGELLON, L. B, TALL, A. R, BRESLOW, J. L

    Published in The Journal of clinical investigation (01-09-1993)
    “…Several types of transgenic mice were used to study the influence of hypertriglyceridemia and cholesteryl ester transfer protein (CETP) expression on high…”
    Get full text
    Journal Article
  5. 5

    Plasma Lp(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the Apo(a) gene by GAVISH, D, AZROLAN, N, BRESLOW, J. L

    “…Plasma Lp(a) levels correlate with atherosclerosis susceptibility. This lipoprotein consists of an LDL-like particle attached to a large glycoprotein called…”
    Get full text
    Journal Article
  6. 6

    Plasma lipoprotein(a) concentration is controlled by apolipoprotein(a) (apo(a)) protein size and the abundance of hepatic apo(a) mRNA in a cynomolgus monkey model by AZROLAN, N, GAVISH, D, BRESLOW, J. L

    Published in The Journal of biological chemistry (25-07-1991)
    “…The cynomolgus macaque was used as a model to study lipoprotein(a) (Lp(a)). Antibodies to Lp(a) were used in Ouchterlony and Western blot analysis to show that…”
    Get full text
    Journal Article
  7. 7

    Dietary Fat Elevates Hepatic ApoA-I Production by Increasing the Fraction of Apolipoprotein A-I mRNA in the Translating Pool (∗) by Azrolan, Neal, Odaka, Hiroyuki, Breslow, Jan L., Fisher, Edward A.

    Published in The Journal of biological chemistry (25-08-1995)
    “…Elevated plasma high density lipoprotein cholesterol (HDL-C) levels are associated with a decreased risk for coronary heart disease. Ironically, diets enriched…”
    Get full text
    Journal Article
  8. 8

    A discoordinate increase in the cellular amount of 3-hydroxy-3-methylglutaryl-CoA reductase results in the loss of rate-limiting control over cholesterogenesis in a tumour cell-free system by Azrolan, N I, Coleman, P S

    Published in Biochemical journal (01-03-1989)
    “…Cholesterol biosynthesis was characterized in cell-free post-mitochondrial supernatant systems prepared from both normal rat liver and Morris hepatoma 3924A…”
    Get full text
    Journal Article
  9. 9

    Human Placental Tissue Expresses a Novel 22.7 kDa Apolipoprotein A-I-like Protein by Richardson, B, Palgunachari, M. N, Anantharamaiah, G. M, Richards, R. G, Azrolan, N, Wiginton, D, Handwerger, S

    Published in Biochemistry (Easton) (11-06-1996)
    “…Since apolipoprotein A-I (apo A-I) and HDL stimulate the expression of the placental hormone human placental lactogen (hPL), experiments were performed to…”
    Get full text
    Journal Article
  10. 10

    Atazanavir Modestly Increases Plasma Levels of Raltegravir in Healthy Subjects by Iwamoto, Marian, Wenning, Larissa A., Mistry, Goutam C., Petry, Amelia S., Liou, Sarah Y., Ghosh, Kaylan, Breidinger, Sheila, Azrolan, Neal, Gutierrez, Maria J., Bridson, William E., Stone, Julie A., Gottesdiener, Keith M., Wagner, John A.

    Published in Clinical infectious diseases (01-07-2008)
    “…Raltegravir is an HIV integrase inhibitor that is metabolized through glucuronidation by uridine diphosphate glucuronosyltransferase 1A1, and its use is…”
    Get full text
    Journal Article
  11. 11

    Effects of Omeprazole on Plasma Levels of Raltegravir by Iwamoto, Marian, Wenning, Larissa A., Nguyen, Bach-Yen, Teppler, Hedy, Moreau, Allison R., Rhodes, Rand R., Hanley, William D., Jin, Bo, Harvey, Charlotte M., Breidinger, Sheila A., Azrolan, Neal, Farmer, H. Frank, Isaacs, Robin D., Chodakewitz, Jeffery A., Stone, Julie A., Wagner, John A.

    Published in Clinical infectious diseases (15-02-2009)
    “…Raltegravir, a human immunodeficiency virus type 1 (HIV-1) integrase inhibitor, has pH-dependent solubility. Raltegravir plasma concentration increases with…”
    Get full text
    Journal Article
  12. 12

    A solution hybridization/RNase protection assay with riboprobes to determine absolute levels of apoB, A-I, and E mRNA in human hepatoma cell lines by Azrolan, N, Breslow, JL

    Published in Journal of lipid research (01-06-1990)
    “…A solution hybridization/RNase protection assay with riboprobes was developed to quantitate apolipoprotein mRNA concentrations. Previously, radiolabeled DNA…”
    Get full text
    Journal Article
  13. 13

    Protective Effect of the Immunosuppressant Sirolimus Against Aortic Atherosclerosis In Apo E‐Deficient Mice by Elloso, M. Merle, Azrolan, Neal, Sehgal, Suren N., Hsu, Pa‐Lang, Phiel, Kristen L., Kopec, Caroline A., Basso, Michael D., Adelman, Steven J.

    Published in American journal of transplantation (01-05-2003)
    “…Atherosclerosis is a chronic inflammatory disease that develops in response to injury to the vessel wall, and is augmented by hypercholesterolemia. To further…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Hypertriglyceridemia as a Result of Human Apo CIII Gene Expression in Transgenic Mice by Ito, Yasushi, Azrolan, Neal, O'Connell, Anita, Walsh, Annemarie, Breslow, Jan L.

    “…Primary and secondary hypertriglyceridemia is common in the general population, but the biochemical basis for this disease is largely unknown. With the use of…”
    Get full text
    Journal Article
  16. 16

    Idea management: restructuring technology-based research to help achieve corporate goals by Azrolan, N, Pavlin, M S

    Published in Drug news & perspectives (01-04-1998)
    “…In order for some technology-based companies to continue to compete, they must consider changes and improvements in the mechanism(s) by which new ideas are…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene by Gavish, D, Azrolan, N, Breslow, J L

    Published in The Journal of clinical investigation (01-12-1989)
    “…Plasma Lp(a) levels correlate with atherosclerosis susceptibility. This lipoprotein consists of an LDL-like particle attached to a large glycoprotein called…”
    Get full text
    Journal Article